Motif Bio plc ADRs
MTFB
MTFB was delisted on the 16th of December, 2019.
3 hedge funds and large institutions have $7.29M invested in Motif Bio plc ADRs in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
18% less capital invested
Capital invested by funds: $8.92M → $7.29M (-$1.63M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$104K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.13K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $7.19M | – | – | – |
|
|
2
Jane Street
New York
| $92K | +$104K | +13,954 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $9K | +$3.13K | +420 | +44% |
|
MTFB Hedge Fund Activity: Q4 2018 in Review
3 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q4 2018, worth a combined $7.29M — down 18% from $8.92M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MTFB positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $104K.
- 3 institutional investors held Motif Bio plc ADRs (MTFB) as of Q4 2018, up from 2 in Q3 2018.
- Funds reported $7.29M of Motif Bio plc ADRs stock for Q4 2018, down 18% quarter-over-quarter.
- 1 fund opened new Motif Bio plc ADRs positions in Q4 2018 and 0 closed out, a net change of +1 holder.
- The largest Motif Bio plc ADRs buyer in Q4 2018 was Jane Street, an estimated $104K added.
Based on aggregated 13F filings for Q4 2018.